Abe K - Search Results

1

cDNA microarray analysis of lactoferrin expression in non-neoplastic human hepatocyte PH5CH8 cells.

Tamura T, Nozaki A, Abe K, Dansako H, Naka K, Ikeda M, Tanaka K, Kato N. Tamura T, et al. Among authors: abe k. Biochim Biophys Acta. 2005 Jan 18;1721(1-3):73-80. doi: 10.1016/j.bbagen.2004.10.003. Epub 2004 Nov 6. Biochim Biophys Acta. 2005. PMID: 15652181

2

cDNA microarray analysis to compare HCV subgenomic replicon cells with their cured cells.

Abe K, Ikeda M, Dansako H, Naka K, Shimotohno K, Kato N. Abe K, et al. Virus Res. 2005 Jan;107(1):73-81. doi: 10.1016/j.virusres.2004.06.013. Virus Res. 2005. PMID: 15567036

3

Genetic variation and dynamics of hepatitis C virus replicons in long-term cell culture.

Kato N, Nakamura T, Dansako H, Namba K, Abe KI, Nozaki A, Naka K, Ikeda M, Shimotohno K. Kato N, et al. Among authors: abe ki. J Gen Virol. 2005 Mar;86(Pt 3):645-656. doi: 10.1099/vir.0.80479-0. J Gen Virol. 2005. PMID: 15722525

4

Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system.

Ikeda M, Abe K, Dansako H, Nakamura T, Naka K, Kato N. Ikeda M, et al. Among authors: abe k. Biochem Biophys Res Commun. 2005 Apr 22;329(4):1350-9. doi: 10.1016/j.bbrc.2005.02.138. Biochem Biophys Res Commun. 2005. PMID: 15766575

5

Mizoribine inhibits hepatitis C virus RNA replication: effect of combination with interferon-alpha.

Naka K, Ikeda M, Abe K, Dansako H, Kato N. Naka K, et al. Among authors: abe k. Biochem Biophys Res Commun. 2005 May 13;330(3):871-9. doi: 10.1016/j.bbrc.2005.03.062. Biochem Biophys Res Commun. 2005. PMID: 15809077

6

Interferon resistance of hepatitis C virus replicon-harbouring cells is caused by functional disruption of type I interferon receptors.

Naka K, Takemoto K, Abe KI, Dansako H, Ikeda M, Shimotohno K, Kato N. Naka K, et al. Among authors: abe ki. J Gen Virol. 2005 Oct;86(Pt 10):2787-2792. doi: 10.1099/vir.0.81124-0. J Gen Virol. 2005. PMID: 16186233

7

Epigenetic silencing of interferon-inducible genes is implicated in interferon resistance of hepatitis C virus replicon-harboring cells.

Naka K, Abe K, Takemoto K, Dansako H, Ikeda M, Shimotohno K, Kato N. Naka K, et al. Among authors: abe k. J Hepatol. 2006 May;44(5):869-78. doi: 10.1016/j.jhep.2006.01.030. Epub 2006 Feb 28. J Hepatol. 2006. PMID: 16545484

8

Different anti-HCV profiles of statins and their potential for combination therapy with interferon.

Ikeda M, Abe K, Yamada M, Dansako H, Naka K, Kato N. Ikeda M, et al. Among authors: abe k. Hepatology. 2006 Jul;44(1):117-25. doi: 10.1002/hep.21232. Hepatology. 2006. PMID: 16799963

9

Tandem repeats of lactoferrin-derived anti-hepatitis C virus peptide enhance antiviral activity in cultured human hepatocytes.

Abe K, Nozaki A, Tamura K, Ikeda M, Naka K, Dansako H, Hoshino HO, Tanaka K, Kato N. Abe K, et al. Microbiol Immunol. 2007;51(1):117-25. doi: 10.1111/j.1348-0421.2007.tb03882.x. Microbiol Immunol. 2007. PMID: 17237607 Free article.

10

Cell culture-adaptive NS3 mutations required for the robust replication of genome-length hepatitis C virus RNA.

Abe K, Ikeda M, Dansako H, Naka K, Kato N. Abe K, et al. Virus Res. 2007 Apr;125(1):88-97. doi: 10.1016/j.virusres.2006.12.011. Epub 2007 Jan 18. Virus Res. 2007. PMID: 17239465

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,010 results

Search Page

Filters